Archive for the ‘
Legal actions ’ Category
Tuesday, November 8th, 2011
(Editor's note: I asked Arnie Friede, an attorney with expertise in FDA and social media regulatory matters, to offer some of his thoughts about these issues on a regular basis. He has obliged, and we'll be hearing from him again. You can also hear Arnie talk with Pharmalot Editor at ...
Posted in
Healthcare ad agencies, Legal actions, Promotional medical education, Social media in pharma, digital advertising |
1 Comment »
Tuesday, June 21st, 2011
With the quickly approaching Aug. 15 deadline for allowing comments on their Facebook walls, pharmaceutical companies are grappling with whether to leave this area of social media all together. Intouch Solutions examined the dilemma and came up with their own solution for pharma: PharmaWall, a Facebook monitoring and moderation tool.
"Facebook’s ...
Posted in
Legal actions, Pharmaceutical operations, Professional education, Promotional medical education, Social media in pharma |
No Comments »
Friday, August 6th, 2010
At first glance, the letter from FDA's DDMAC about Novartis' Facebook Share widget for the cancer drug Tasigna seems to be a case of the regulatory agency being digitally backward.
But not so, says Bruce Grant, senior VP of business strategy at Digitas Health. He argues that FDA wasn't making a ...
Posted in
Legal actions, Social media in pharma |
3 Comments »
Thursday, June 10th, 2010
The June issues of Med Ad News and R&D Directions are now online, and between the two issues you’ll find substantial coverage of what the provisions in the new healthcare reform legislation will mean for the pharmaceutical and biotechnology industries.
In Med Ad News’ 19th annual Top 100 Biotechnology Companies report, ...
Posted in
Legal actions, Med Ad News |
No Comments »
Thursday, May 6th, 2010
Med Ad News’ 19th annual report on the Top 100 Biotechnology Companies in our upcoming June issue will explore the impact of U.S. healthcare reform legislation on the biotech industry. Of particular note for the industry is a provision establishing the therapeutic discovery project tax credit.
The bill provides up to ...
Posted in
Legal actions, R&D Directions |
No Comments »
Thursday, April 22nd, 2010
Tonight, following the 21st Annual Manny Awards honoring outstanding acheivements in healthcare advertising, our April issue will be unveiled along with all the winners. Meanwhile, our May issue, including one of our regular features on promotional medical education, is in full production.
For last year’s promotional medical education feature, I had ...
Posted in
Behind the scenes, Legal actions, Manny Awards, Promotional medical education, Sales & Marketing |
1 Comment »
Thursday, February 11th, 2010
This month, General Motors took advantage of Toyota's recall misfortune and public relations silence by revealing a shiny new purchase-and-lease incentive program targeting Toyota and Lexus customers. GM's program running through February, allows Toyota owners who end their lease to receive up to $1,000 off a new or leased GM ...
Posted in
Adwise, DTC advertising, Legal actions, Manny Awards, Pharma Business, Sales & Marketing, Sales force effectiveness, Uncategorized, blogs |
No Comments »
Monday, December 21st, 2009
Healthcare reform has taken a major step forward as the Democratic caucus voted to curtail debate on the bill. The final vote on the Senate’s version of healthcare reform could come by Christmas, at which point the Senate must then draft a compromise with the House, which approved its own ...
Posted in
Legal actions, Pharma Business, Pharmaceutical operations, Sales & Marketing |
1 Comment »
Wednesday, December 2nd, 2009
Healthcare reform and changing business models could have profound tax implications for the pharmaceutical industry.
Yesterday, PricewaterhouseCoopers announced a new report called “Pharma 2020: Taxing times ahead - Which path will you take?”, which looks at the forces that are driving up the effective tax rate for pharmaceutical and life sciences ...
Posted in
Economy, Legal actions, Pharma Business, Pharmaceutical operations |
1 Comment »
Monday, August 10th, 2009
As the debate over government involvement in healthcare builds in the United States, a battle between pharmacists and the government health authority in the Republic of Ireland over the last several weeks is offering policymakers a real-world lesson in the challenges of public administration of healthcare.
The troubles began June 18, ...
Posted in
Economy, Legal actions |
No Comments »
|
|
